Cablivi (caplacizumab) is the first medicine approved for the treatment of adult patients with acquired thrombotic thrombocytopenic purpura (aTTP)1,2. It is available in powder form or solution for injection, to be used in combination with plasma exchange and immunosuppressive therapy1,2. How does Cablivi (caplacizumab) work